Pegylated interferon-alfa-2A plus adefovir combination therapy is superior to pegylated interferon-alfa-2A alone or adefovir monotherapy in reducing HBsAg levels in hdvcoinfected patients with low HBV viremia
| dc.contributor.author | Wedemeyer, Heiner | |
| dc.contributor.author | Manns, Michael P. | |
| dc.contributor.author | Dalekos, George | |
| dc.contributor.author | Bock, Thomas | |
| dc.contributor.author | Zeuzem, Stefan | |
| dc.contributor.author | Drebber, Ulrike | |
| dc.contributor.author | Cakaloglu, Ya | |
| dc.contributor.author | Degertekin, Ha | |
| dc.contributor.author | Gurel, Sa | |
| dc.contributor.author | Zachou, Kalliopi | |
| dc.contributor.author | Yurdaydin, Cihan | |
| dc.contributor.author | Erhardt, Alexander | |
| dc.date.accessioned | 2021-03-05T13:53:23Z | |
| dc.date.available | 2021-03-05T13:53:23Z | |
| dc.identifier.citation | Wedemeyer H., Yurdaydin C., Zachou K., Erhardt A., Drebber U., Cakaloglu Y., Degertekin H., Gurel S., Zeuzem S., Bock T., et al., "Pegylated interferon-alfa-2A plus adefovir combination therapy is superior to pegylated interferon-alfa-2A alone or adefovir monotherapy in reducing HBsAg levels in hdvcoinfected patients with low HBV viremia", 57th Annual Meeting of the American-Association-for-the-Study-of-Liver-Diseases, Massachusetts, Amerika Birleşik Devletleri, 27 - 31 Ekim 2006, cilt.44 | |
| dc.identifier.other | av_b46c24d7-ef7e-42d8-9238-1283cd92a745 | |
| dc.identifier.other | vv_1032021 | |
| dc.identifier.uri | http://hdl.handle.net/20.500.12627/120155 | |
| dc.language.iso | eng | |
| dc.subject | GASTROENTEROLOJİ VE HEPATOLOJİ | |
| dc.subject | Klinik Tıp | |
| dc.subject | Klinik Tıp (MED) | |
| dc.subject | Tıp | |
| dc.subject | Sağlık Bilimleri | |
| dc.subject | Dahili Tıp Bilimleri | |
| dc.subject | İç Hastalıkları | |
| dc.subject | Gastroenteroloji-(Hepatoloji) | |
| dc.title | Pegylated interferon-alfa-2A plus adefovir combination therapy is superior to pegylated interferon-alfa-2A alone or adefovir monotherapy in reducing HBsAg levels in hdvcoinfected patients with low HBV viremia | |
| dc.type | Bildiri | |
| dc.contributor.department | , , | |
| dc.identifier.volume | 44 | |
| dc.contributor.firstauthorID | 132857 |
Bu öğenin dosyaları:
| Dosyalar | Boyut | Biçim | Göster |
|---|---|---|---|
|
Bu öğe ile ilişkili dosya yok. |
|||
Bu öğe aşağıdaki koleksiyon(lar)da görünmektedir.
-
Bildiri [64839]